Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

893 recalls · Class II, newest first

Class II · Moderate risk

Medline I&D Tray Kit

Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.

Terminated Wrong potency / content Medline Industries Inc D-0268-2018
Class II · Moderate risk

Medline IV Start Kit

Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.

Terminated Wrong potency / content Medline Industries Inc D-0265-2018
Class II · Moderate risk

Medline TRAY

Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.

Terminated Wrong potency / content Medline Industries Inc D-0263-2018
Class II · Moderate risk

Medline Trunk Kit

Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%.

Terminated Wrong potency / content Medline Industries Inc D-0262-2018
Class II · Moderate risk

ChloraPrep OneStep

Labeling; Label Mixup; the immediate package is labeled incorrectly as Chloroprep Onestep (Clear), however, the correct label should be Chloroprep with Tint (Hi Lite Orange)

Terminated Labeling / mix-up Becton Dickinson & Company D-0029-2018
Class II · Moderate risk

Aminocaproic Acid

CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use.

Terminated Labeling / mix-up Medisca, Inc. NDC 38779-0989-05 D-1174-2017
Class II · Moderate risk

Procrit (epoetin alfa)

Presence of particulate matter: glass flakes identified as lamellae observed during a routine quality inspection.

Terminated Particulate / foreign matter Amgen, Inc. NDC 59676-310-01 D-1173-2017
Class II · Moderate risk

Acarbose Tablets

Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.

Terminated Labeling / mix-up Teva Pharmaceuticals USA NDC 16252-523-01 D-1178-2017
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0160-2018
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0159-2018

Recalls by year